• Explore /
  • Poster
  • / Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.

Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.

Abstract Poster

Authors

null

Michael Yan

Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada

Michael Yan , Zhihao Li , Pablo Muñoz-Schuffenegger , Anna Santiago , Marco Claasen , Roxana Bucur , Ian M. McGilvray , Carol-Anne Moulton , Trevor Reichman , Chaya Shwaartz , Sean P. Cleary , Grainne M. O'Kane , Robert C Grant , Tae Kim , Catherine Soo Yee Naidoo , Ali Hosni , Rebecca KS Wong , Aruz Mesci , Gonzalo Sapisochin , Laura A. Dawson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 521)

DOI

10.1200/JCO.2024.42.3_suppl.521

Abstract #

521

Poster Bd #

E8

Abstract Disclosures

Similar Posters

First Author: Feng Ming Kong

First Author: Sadahisa Ogasawara

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

First Author: Timothy J Brown

First Author: Yixing Chen